Injective has extended its upward trajectory on Friday, building on an 11% rebound recorded a day earlier as broader investor sentiment responded positively to major regulatory developments. The digital asset is approaching the $9 threshold, pushing past recent consolidation ranges. This sustained advance comes at a critical juncture when several broader market assets are facing macro-driven headwinds, highlighting a decoupling driven by targeted ecosystem achievements and strong on-chain fundamentals.
High-Level Washington Meetings on Tokenization Frameworks
The primary catalyst behind the renewed momentum is high-level engagement between Injective leadership and key American regulators. On Wednesday, Injective Chief Executive Officer Eric Chen met with senior policymakers at the White House, alongside top officials from the US Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC). The central focus of these discussions was accelerating on-chain finance and advanced asset tokenization within compliant regulatory frameworks.
Injective has systematically aligned its technical infrastructure with official standards. Notable operational milestones include securing SEC-registered transfer agent status to facilitate tokenized securities, introducing CFTC-regulated futures contracts for the native INJ token, and deploying the Injective mint tailored for Real-World Assets (RWAs) under an SEC innovation exemption. Direct dialogue with federal agencies underscores a strategic push to bridge institutional capital with decentralized financial rails.
Social Interest Climbs Alongside Investor Sentiment
Confirmation of these regulatory discussions quickly translated into heightened community engagement. According to data provided by Santiment, Injective's social dominance rose to 1.1% on Friday, meaning roughly 1% of all discussions across crypto-specific social channels centered on the asset. This sudden expansion in social footprint directly coincided with public details regarding Eric Chen's Washington agenda, reinforcing broader confidence among market participants looking for compliance-focused projects.
Exchange Outflows Signal Diminishing Selling Pressure
Beyond headline sentiment, verifiable ledger activity demonstrates structural accumulation by holders. Santiment figures reveal that non-exchange whale wallets expanded their aggregate holdings to 95.46 million INJ on Thursday, up from 94.99 million recorded on August 12. Concurrently, liquid supply residing on centralized exchanges declined from 1.26 million INJ down to 872,500 INJ, indicating a steady transfer of tokens toward cold storage and non-custodial custody.
This persistent drain on exchange liquidity significantly curtails immediate sell-side pressure. Furthermore, 77.01% of the circulating INJ supply is now holding an unrealized profit, marking a dramatic increase from 41.16% observed during the comparable baseline period. The confluence of rising profitability and reduced trading inventory often establishes a firmer floor against sudden price corrections.
Technical Structure and Key Price Thresholds
From a chart perspective, Injective traded near $8.71 on Friday, sustaining a recovery that originated from its 50-day Exponential Moving Average (EMA) at $6.59 last week. Current dynamic averages place the 50-day EMA at $6.94 and the longer-term 200-day EMA at $5.76. Remaining well above both moving averages preserves an active bullish bias in the medium term.
Momentum oscillators reflect constructive conditions without signaling exhaustion. The Moving Average Convergence Divergence (MACD) indicator continues to print within positive territory, supported by modest green bars on the histogram. Simultaneously, the 14-day Relative Strength Index (RSI) sits near 62, reflecting solid buying interest while remaining comfortably below the overbought barrier. By breaking through the $8.21 resistance level established by the October 11 low, INJ has cleared a path toward the October 13 high of $10.09, followed by the secondary target at $12.44, representing the peak from October 10. Downward pullbacks would look to the 50-day EMA at $6.94 for primary defense, with structural support anchored at the 200-day EMA near $5.76.
Macro Headwinds Across Broader Crypto Markets
Injective's technical breakout stands out against a backdrop of widespread caution across the wider cryptocurrency complex. Market participants have contended with hotter-than-projected US inflation data, prompting a retreat in speculative risk appetite. Bitcoin dropped below $81,000 on Thursday, retesting its primary demand zone near $80,000 as institutional demand softened, evidenced by more than $261 million in net outflows from spot BTC exchange-traded funds on Wednesday. Live market pricing places Bitcoin around $82,015 with an RSI of 48 and an MACD histogram at -546.23, reflecting short-term consolidation.
Altcoins have broadly tracked this cautious sentiment. Ethereum drifted below $2,400 amid technical deterioration, while cross-border settlement token Ripple traded near $1.30 on Thursday under extended bearish pressure. In contrast, Pi Network registered modest movement, advancing from $0.0740 to $0.0780 ahead of its scheduled Protocol v28 Mainnet upgrade aimed at smart contract maintenance and data processing. Amid these mixed dynamics, Injective's gains underscore the influence of institutional dialogue on individual asset performance.
